Vapiprost
| Code | Size | Price |
|---|
| TAR-T24931-5mg | 5mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Vapiprost is an antagonist of the thromboxane receptor and a prostaglandin receptor.
CAS:
85505-64-2
Formula:
C30H39NO4
Molecular Weight:
477.645
Purity:
0.98
SMILES:
O[C@H]1C[C@H](OCc2ccc(cc2)-c2ccccc2)[C@H](CCC=C/CCC(O)=O)[C@H]1N1CCCCC1
References
1. Uematsu T, Nagashima S, Mizuno A, Hirano K, Nakashima M. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers. J Clin Pharmacol. 1991 Sep;31(9):815-22. PubMed PMID: 1839540.
2. Nishiyama H, Umemura K, Saniabadi AR, Takiguchi Y, Uematsu T, Nakashima M. Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model. Eur J Pharmacol. 1994 Oct 24;264(2):191-8. PubMed PMID: 7851482.
3. Kan KK, Jones RL, Ngan MP, Rudd JA. Action of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew). Eur J Pharmacol. 2003 Sep 23;477(3):247-51. PubMed PMID: 14522363.
4. Matsuzaki T, Noguchi K, Nakasone J, Uezu K, Higuchi M, Sakanashi M. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels. Arzneimittelforschung. 1992 Nov;42(11):1318-22. PubMed PMID: 1492844.